drugset / Trial / NCT01641042
Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to investigate the immunogenicity, reactogenicity and safety of the new meningococcal vaccine 134612 in subjects with increased risk of meningococcal disease and compare it to its activity in healthy subjects.
Timeline
- Start
- 2012-09-10
- Primary completion
- 2014-10-10
- Completion
- 2015-03-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK134612 | Vaccine | — | Intramuscular |